Home/Filings/4/0001104659-25-058597
4//SEC Filing

MOLINA ARTURO MD 4

Accession 0001104659-25-058597

CIK 0001377121other

Filed

Jun 10, 8:00 PM ET

Accepted

Jun 11, 5:40 PM ET

Size

14.9 KB

Accession

0001104659-25-058597

Insider Transaction Report

Form 4
Period: 2025-06-09
MOLINA ARTURO MD
Chief Medical Officer
Transactions
  • Exercise/Conversion

    Stock Option (right to buy)

    2025-06-0910,00085,971 total
    Exercise: $8.04Exp: 2032-11-15Common Stock (10,000 underlying)
  • Exercise/Conversion

    Common Stock

    2025-06-09$8.04/sh+10,000$80,40093,892 total
  • Sale

    Common Stock

    2025-06-09$55.51/sh10,000$555,10083,892 total
  • Exercise/Conversion

    Common Stock

    2025-06-10$8.04/sh+10,000$80,40093,892 total
  • Sale

    Common Stock

    2025-06-10$57.03/sh10,000$570,30083,892 total
  • Exercise/Conversion

    Stock Option (right to buy)

    2025-06-1010,00075,971 total
    Exercise: $8.04Exp: 2032-11-15Common Stock (10,000 underlying)
Footnotes (3)
  • [F1]The price reported represents the weighted average sale price per share. The shares were sold in multiple transactions at prices ranging from $55.18 to $55.75. Upon request by the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.
  • [F2]The price reported represents the weighted average sale price per share. The shares were sold in multiple transactions at prices ranging from $56.665 to $57.48. Upon request by the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.
  • [F3]The stock option represents a right to purchase a total of 127,500 shares of the Issuer's common stock, one quarter of which vested on November 7, 2023, with the remaining three quarters vesting in equal monthly installments through November 7, 2026, subject to the Reporting Person's continued service to the Issuer.

Issuer

Protagonist Therapeutics, Inc

CIK 0001377121

Entity typeother

Related Parties

1
  • filerCIK 0001398940

Filing Metadata

Form type
4
Filed
Jun 10, 8:00 PM ET
Accepted
Jun 11, 5:40 PM ET
Size
14.9 KB